Photo by stayandroam from unsplash
To evaluate whether there is a difference between the effects of dapagliflozin and gliclazide modified release (MR) on glycaemic variability (GV) and glycaemic control, as assessed by continuous glucose monitoring… Click to show full abstract
To evaluate whether there is a difference between the effects of dapagliflozin and gliclazide modified release (MR) on glycaemic variability (GV) and glycaemic control, as assessed by continuous glucose monitoring (CGM), in individuals with uncontrolled type 2 diabetes.
Keywords:
glycaemic variability;
gliclazide modified;
type diabetes;
modified release;
glucose monitoring;
continuous glucose
Journal Title: Diabetes
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diabetes
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!